Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
July 10, 2026
Prognostic value of plasma brain-derived pTau
Valentina Ghisays, Marisa N Denkinger, Alpana Singh, et al.
Journal of Alzheimer'S Disease : JAD
|
September 14, 2020
Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study
Clara Vila-Castelar, Edmarie Guzmán-Vélez, Enmanuelle Pardilla-Delgado, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 25, 2024
Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies
Pierre N Tariot, Marie-Emmanuelle Riviere, Stephen Salloway, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Kathryn L Ghisays, Deborah Brostrom, Robert J Bauer, et al.
Applied Neuropsychology. Adult
|
June 25, 2019
Normative data stratified by age and education for a Spanish neuropsychological test battery: Results from the Colombian Alzheimer's prevention initiative registry
Valeria L Torres, Clara Vila-Castelar, Yamile Bocanegra, et al.
Journal of Alzheimer'S Disease : JAD
|
August 28, 2023
Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia
Claudia Ramos, Claudia Madrigal, Daniel Camilo Aguirre-Acevedo, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 30, 2018
The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical <i>PSEN1</i> E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort
Pierre N Tariot, Francisco Lopera, Jessica B Langbaum, et al.
The Lancet. Healthy Longevity
|
November 30, 2025
Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer's Prevention Initiative Generation Study 1
Jessica B Langbaum, Angela R Bradbury, Brian L Egleston, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 30, 2018
Measuring cognition and function in the preclinical stage of Alzheimer's disease
Sandra Weintraub, Maria C Carrillo, Sarah Tomaszewski Farias, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 10, 2022
Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials
Jessica B Langbaum, Julie Zissimopoulos, Rhoda Au, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Medrxiv : the Preprint Server for Health Sciences
|
July 10, 2026
Prognostic value of plasma brain-derived pTau
Valentina Ghisays, Marisa N Denkinger, Alpana Singh, et al.
Journal of Alzheimer'S Disease : JAD
|
September 14, 2020
Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study
Clara Vila-Castelar, Edmarie Guzmán-Vélez, Enmanuelle Pardilla-Delgado, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 25, 2024
Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies
Pierre N Tariot, Marie-Emmanuelle Riviere, Stephen Salloway, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Kathryn L Ghisays, Deborah Brostrom, Robert J Bauer, et al.
Applied Neuropsychology. Adult
|
June 25, 2019
Normative data stratified by age and education for a Spanish neuropsychological test battery: Results from the Colombian Alzheimer's prevention initiative registry
Valeria L Torres, Clara Vila-Castelar, Yamile Bocanegra, et al.
Journal of Alzheimer'S Disease : JAD
|
August 28, 2023
Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia
Claudia Ramos, Claudia Madrigal, Daniel Camilo Aguirre-Acevedo, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 30, 2018
The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical <i>PSEN1</i> E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort
Pierre N Tariot, Francisco Lopera, Jessica B Langbaum, et al.
The Lancet. Healthy Longevity
|
November 30, 2025
Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer's Prevention Initiative Generation Study 1
Jessica B Langbaum, Angela R Bradbury, Brian L Egleston, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 30, 2018
Measuring cognition and function in the preclinical stage of Alzheimer's disease
Sandra Weintraub, Maria C Carrillo, Sarah Tomaszewski Farias, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 10, 2022
Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials
Jessica B Langbaum, Julie Zissimopoulos, Rhoda Au, et al.
Page
of 7